Xenon Pharmaceuticals Inc (XENE)
40.10
+0.60
(+1.52%)
USD |
NASDAQ |
Apr 25, 16:00
40.12
+0.02
(+0.05%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap: 3.025B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.025B |
| April 24, 2024 | 2.980B |
| April 23, 2024 | 3.100B |
| April 22, 2024 | 3.018B |
| April 19, 2024 | 3.008B |
| April 18, 2024 | 3.041B |
| April 17, 2024 | 3.140B |
| April 16, 2024 | 3.130B |
| April 15, 2024 | 3.116B |
| April 12, 2024 | 3.115B |
| April 11, 2024 | 3.241B |
| April 10, 2024 | 3.201B |
| April 09, 2024 | 3.246B |
| April 08, 2024 | 3.215B |
| April 05, 2024 | 3.187B |
| April 04, 2024 | 3.184B |
| April 03, 2024 | 3.115B |
| April 02, 2024 | 3.128B |
| April 01, 2024 | 3.179B |
| March 28, 2024 | 3.247B |
| March 27, 2024 | 3.244B |
| March 26, 2024 | 3.218B |
| March 25, 2024 | 3.221B |
| March 22, 2024 | 3.319B |
| March 21, 2024 | 3.278B |
| Date | Value |
|---|---|
| March 20, 2024 | 3.303B |
| March 19, 2024 | 3.345B |
| March 18, 2024 | 3.235B |
| March 15, 2024 | 3.316B |
| March 14, 2024 | 3.294B |
| March 13, 2024 | 3.400B |
| March 12, 2024 | 3.338B |
| March 11, 2024 | 3.347B |
| March 08, 2024 | 3.488B |
| March 07, 2024 | 3.482B |
| March 06, 2024 | 3.467B |
| March 05, 2024 | 3.470B |
| March 04, 2024 | 3.466B |
| March 01, 2024 | 3.533B |
| February 29, 2024 | 3.560B |
| February 28, 2024 | 3.609B |
| February 27, 2024 | 3.744B |
| February 26, 2024 | 3.706B |
| February 23, 2024 | 3.728B |
| February 22, 2024 | 3.712B |
| February 21, 2024 | 3.680B |
| February 20, 2024 | 3.649B |
| February 16, 2024 | 3.686B |
| February 15, 2024 | 3.670B |
| February 14, 2024 | 3.655B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
209.79M
Minimum
Oct 09 2019
3.772B
Maximum
Feb 09 2024
1.383B
Average
1.351B
Median
May 09 2022
Market Cap Benchmarks
| Acasti Pharma Inc | 27.53M |
| Aurinia Pharmaceuticals Inc | 704.29M |
| Edesa Biotech Inc | 14.17M |
| Lexaria Bioscience Corp | 28.22M |
| ESSA Pharma Inc | 270.74M |
Market Cap Related Metrics
| PS Ratio | 203.65 |
| PEG Ratio | -1.048 |
| Price to Book Value | 3.260 |
| Price | 40.10 |
| Earnings Yield | -6.78% |
| PEGY Ratio | -1.048 |